NCT04605952View on ClinicalTrials.gov

Study to Find the Percentage of Cases Retaining COVID-19 IgG Antibodies 45-65 After They Have Tested Positive

CompletedOBSERVATIONAL
Enrollment

201

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

August 30, 2020

Study Completion Date

August 30, 2020

Conditions
Covid19
Interventions
DIAGNOSTIC_TEST

Repeat SARS-CoV-2 IgG antibodies at 45-65 days

All cases who initially tested positive for SARS-CoV-2 IgG antibodies would undergo a repeat test at 45-65 days

Trial Locations (1)

831011

Dr.Deb Sanjay Nag, Jamshedpur

All Listed Sponsors
lead

Tata Main Hospital

OTHER

NCT04605952 - Study to Find the Percentage of Cases Retaining COVID-19 IgG Antibodies 45-65 After They Have Tested Positive | Biotech Hunter | Biotech Hunter